Emerging trends in pharmaceutical design and drug manufacturing are shifting toward presenting the market with new ways to develop medications. Specialty medications continue to be a major area of pharmaceutical development and have become widely discussed in workers’ comp due to their significant costs. Although they represent approximately 1% of drug utilization, they account for nearly 7% of prescription drug costs and represent the fastest-growing segment of the U.S. pharmaceutical market. While specialty drug products are often associated with a hefty price tag, some can offer clinical advantages when deployed for the right patient at the right time, making careful oversight and patient selection imperative to achieving desired outcomes in this space. Watch the video blog to learn more.
More stories
Workers' Comp
News Release
Genex Services Outlines Top Barriers to Effective Return-to-Work Programs
Notes strong RTW programs reduce disability duration for costly long term disability case
Business Insurance
In the News
Traffic accidents are a leading cause of serious workers comp injuries
Risk managers overseeing commercial transportation fleets have long focused on the issue of truck driver safety, but other companies also should pay greater attention to employees’ distracted driving that is causing many catastrophic workers compensation claims.
Workers' Comp
News Release
WorkCompCentral: Payers, Regulators Push for Limits on 2 Chronic Pain Treatments
Read here with subscription.
Workers' Comp
News Release
Genex Announces Case Manager Scholarship Award Recipients
WAYNE, Pa.
Workers' Comp
White Paper
Essentials of Return to Work Series
“Essentials of Return to Work” is a four-part thought leadership series addressing the challenges and strategies to accelerate return to work for injured employees.
APAX
News Release
Funds advised by Apax Partners acquire GENEX Services
https://www.apax.com/news-views/funds-advised-by-apax-partners-acquire-genex-services/